Vesicular Stomatitis Virus as a Novel Cancer Vaccine Vector to Prime Antitumor Immunity Amenable to Rapid Boosting With Adenovirus

Vesicular stomatitis virus (VSV) has proven to be an effective vaccine vector for immunization against viral infection, but its potential to induce an immune response to a self-tumor antigen has not been investigated. We constructed a recombinant VSV expressing human dopachrome tautomerase (hDCT) an...

Full description

Saved in:
Bibliographic Details
Main Authors: Bridle, Byram W, Boudreau, Jeanette E, Lichty, Brian D, Brunellière, Jérôme, Stephenson, Kyle, Koshy, Sandeep, Bramson, Jonathan L, Wan, Yonghong
Format: Artigo
Language:Inglês
Published: Nature Publishing Group 2009
Subjects:
Original Articles
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC2835010/
https://ncbi.nlm.nih.gov/pubmed/19603003
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/mt.2009.154
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items